By expenditures
| Name | Title | Type |
|---|---|---|
| Jason Askin | Controler | Auditee |
| Chris J Suda | Principal | Auditee |
| Kelly Kirkman | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 392281 | 2025 | 2026-03-17 | RSM US LLP | $129.64M |
| 348932 | 2024 | 2025-03-27 | Rsm US LLP | $121.23M |
| 299258 | 2023 | 2024-03-28 | Rsm US LLP | $126.67M |
| 41348 | 2022 | 2023-03-29 | Cliftonlarsonallen LLP | $162.65M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 392281 | 2025 | 2026-03-17 | 1179944 | 2025-005 | Material Weakness | Yes | N |
| 392281 | 2025 | 2026-03-17 | 1179943 | 2025-004 | Material Weakness | Yes | I |
| 392281 | 2025 | 2026-03-17 | 1179942 | 2025-004 | Material Weakness | Yes | I |
| 392281 | 2025 | 2026-03-17 | 1179941 | 2025-004 | Material Weakness | Yes | I |
| 392281 | 2025 | 2026-03-17 | 1179940 | 2025-003 | Material Weakness | Yes | N |
| 392281 | 2025 | 2026-03-17 | 1179939 | 2025-003 | Material Weakness | Yes | N |
| 348932 | 2024 | 2025-03-27 | 1114086 | 2024-004 | Material Weakness | - | I |
| 348932 | 2024 | 2025-03-27 | 1114085 | 2024-003 | Significant Deficiency | - | N |
| 348932 | 2024 | 2025-03-27 | 537644 | 2024-004 | Material Weakness | - | I |
| 348932 | 2024 | 2025-03-27 | 537643 | 2024-003 | Significant Deficiency | - | N |
| 299258 | 2023 | 2024-03-28 | 963380 | 2023-007 | Significant Deficiency | - | L |
| 299258 | 2023 | 2024-03-28 | 963379 | 2023-006 | Significant Deficiency | - | H |
| 299258 | 2023 | 2024-03-28 | 963378 | 2023-005 | Significant Deficiency | - | C |
| 299258 | 2023 | 2024-03-28 | 963377 | 2023-005 | Significant Deficiency | - | C |
| 299258 | 2023 | 2024-03-28 | 963376 | 2023-005 | Significant Deficiency | - | C |
| 299258 | 2023 | 2024-03-28 | 963375 | 2023-005 | Significant Deficiency | - | C |
| 299258 | 2023 | 2024-03-28 | 386938 | 2023-007 | Significant Deficiency | - | L |
| 299258 | 2023 | 2024-03-28 | 386937 | 2023-006 | Significant Deficiency | - | H |
| 299258 | 2023 | 2024-03-28 | 386936 | 2023-005 | Significant Deficiency | - | C |
| 299258 | 2023 | 2024-03-28 | 386935 | 2023-005 | Significant Deficiency | - | C |
| 299258 | 2023 | 2024-03-28 | 386934 | 2023-005 | Significant Deficiency | - | C |
| 299258 | 2023 | 2024-03-28 | 386933 | 2023-005 | Significant Deficiency | - | C |